Healthcare DIVE June 21, 2021
Dive Brief:
- CMS opened up Medicare coverage for therapeutic continuous glucose monitors, eliminating a rule that beneficiaries must use a blood glucose monitor and require at least four self-monitoring blood glucose (SMBG) tests per day to have devices covered.
- CMS eliminated the requirement because “there is no evidence to support that frequent SMBG (≥4 times per day) as a prerequisite for initiating CGM use is predictive of improved health outcomes,” according to the local coverage determination document. The coverage change, published June 3, will take effect July 18.
- Top CGM makers Abbott Laboratories and Dexcom said in emailed statements that opening up eligibility will improve patient access to CGMs. “Medicare’s coverage change has the potential to significantly expand the...
Today's Sponsors
Today's Sponsor
Topics: CMS, Digital Health, Govt Agencies, Health IT, Insurance, Medicare, Patient / Consumer, Provider, Technology, Wearables